The Web's First Cancer Resource OncoLink en espanolOncoLink en espanõl
Quick Search: advanced search
OncoLink Cancer Resources
OncoLink Cancer Resources
Saturday, November 21, 2009
OncoLink Cancer Resources

Ask the Experts

OncoLink en espanol Espanõl

emailPrint Article
emailEmail Article

OncoLink - Share Share

Ask the Experts Archive > Types of Cancer > Gynecologic Cancers > Endometrial and Uterine Cancer

Risk of Lymphedema with TAH/BSO & Lymphadenectomy

Affiliation: Abramson Cancer Center of the University of Pennsylvania
Last Modified: July 18, 2008

Question

Dear OncoLink "Ask The Experts,"

What is the risk of lymphedema following a complete lymphadenectomy accompanying TAH BSO? How well documented, prospectively, is the occurrence of lymphedema in this patient population?

Answer

Christina S. Chu, MD, Assistant Professor of the Division of Gynecologic Oncology at the University of Pennsylvania Health System, responds:

The incidence of lymphedema following pelvic lymph node sampling and hysterectomy for treatment of endometrial cancer varies from about 2% to 11%, according to retrospective studies. The incidence likely varies depending on how much lymphatic tissue was removed.

See this previous question about lower extremity lymphedema.